Methamphetamine use in the United States: epidemiological update and implications for prevention, treatment, and harm reduction.
methamphetamine
opioid
overdose
Journal
Annals of the New York Academy of Sciences
ISSN: 1749-6632
Titre abrégé: Ann N Y Acad Sci
Pays: United States
ID NLM: 7506858
Informations de publication
Date de publication:
02 2022
02 2022
Historique:
revised:
04
08
2021
received:
16
05
2021
accepted:
19
08
2021
pubmed:
26
9
2021
medline:
11
3
2022
entrez:
25
9
2021
Statut:
ppublish
Résumé
Recent attention has focused on the growing role of psychostimulants, such as methamphetamine in overdose deaths. Methamphetamine is an addictive and potent stimulant, and its use is associated with a range of physical and mental health harms, overdose, and mortality. Adding to the complexity of this resurgent methamphetamine threat is the reality that the increases in methamphetamine availability and harms are occurring in the midst of and intertwined with the ongoing opioid overdose crisis. Opioid involvement in psychostimulant-involved overdose deaths increased from 34.5% of overdose deaths in 2010 to 53.5% in 2019-an increase of more than 50%. This latest evolution of the nation's overdose epidemic poses novel challenges for prevention, treatment, and harm reduction. This narrative review synthesizes what is known about changing patterns of methamphetamine use with and without opioids in the United States, other characteristics associated with methamphetamine use, the contributions of the changing illicit drug supply to use patterns and overdose risk, motivations for couse of methamphetamine and opioids, and awareness of exposure to opioids via the illicit methamphetamine supply. Finally, the review summarizes illustrative community and health system strategies and research opportunities to advance prevention, treatment, and harm reduction policies, programs, and practices.
Identifiants
pubmed: 34561865
doi: 10.1111/nyas.14688
pmc: PMC9097961
mid: NIHMS1791134
doi:
Substances chimiques
Illicit Drugs
0
Methamphetamine
44RAL3456C
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3-22Subventions
Organisme : Intramural CDC HHS
ID : CC999999
Pays : United States
Informations de copyright
Published 2021. This article is a U.S. government work and is in the public domain in the USA.
Références
MMWR Morb Mortal Wkly Rep. 2021 Feb 12;70(6):202-207
pubmed: 33571180
Addict Behav. 2018 Nov;86:104-110
pubmed: 29544869
Sex Transm Infect. 2015 Dec;91(8):598-602
pubmed: 25921020
Int J Drug Policy. 2020 Apr 17;79:102722
pubmed: 32311513
AIDS Behav. 2021 Apr;25(4):1210-1218
pubmed: 33185774
JAMA Psychiatry. 2021 May 1;78(5):564-567
pubmed: 33471025
J Psychiatry Neurosci. 2006 Sep;31(5):301-13
pubmed: 16951733
Psychol Med. 2017 Oct;47(13):2246-2259
pubmed: 28399955
Drug Alcohol Depend. 2020 Nov 1;216:108243
pubmed: 32911134
MAbs. 2014 Mar-Apr;6(2):547-55
pubmed: 24492290
Subst Use Misuse. 2017 Jul 3;52(8):1051-1058
pubmed: 28323507
Int J Drug Policy. 2019 Aug;70:22-32
pubmed: 31059965
Addiction. 2020 Feb;115(2):347-353
pubmed: 31503384
J Pediatr. 2020 Sep;224:102-109.e3
pubmed: 32437756
Int J Drug Policy. 2020 Mar;77:102665
pubmed: 31962283
Am J Addict. 2021 Mar;30(2):183-191
pubmed: 33301230
Pharmacol Res. 2017 Jun;120:60-67
pubmed: 28302577
Int J Drug Policy. 2012 Nov;23(6):426-35
pubmed: 22943831
Drug Alcohol Depend. 2021 Aug 1;225:108750
pubmed: 34052690
Harm Reduct J. 2015 Nov 14;12:54
pubmed: 26577516
Int J Drug Policy. 2018 Apr;54:43-50
pubmed: 29414484
N Engl J Med. 2019 May 23;380(21):1988-1990
pubmed: 31042821
PLoS One. 2020 Jun 18;15(6):e0234809
pubmed: 32555667
Expert Rev Vaccines. 2020 Dec;19(12):1105-1114
pubmed: 33251859
JAMA Psychiatry. 2020 Sep 1;77(9):959-966
pubmed: 32267484
Prev Med. 2019 Nov;128:105813
pubmed: 31437462
Drug Discov Today. 2020 Mar;25(3):610-619
pubmed: 31419495
J Psychoactive Drugs. 2010 Mar;42(1):11-8
pubmed: 20464802
Am J Prev Med. 2007 May;32(5):395-402
pubmed: 17478265
Am J Public Health. 2019 Jun;109(S3):S185-S189
pubmed: 31242006
MMWR Suppl. 2020 Aug 21;69(1):38-46
pubmed: 32817608
MMWR Morb Mortal Wkly Rep. 2020 Sep 04;69(35):1189-1197
pubmed: 32881854
Drug Alcohol Depend. 2017 Oct 1;179:174-179
pubmed: 28787694
J Addict Med. 2020 Jul/Aug;14(4):e8-e9
pubmed: 32404652
Clin Toxicol (Phila). 2021 Aug;59(8):705-714
pubmed: 33403876
Health Promot Pract. 2019 Jul;20(4):553-564
pubmed: 30205737
Subst Use Misuse. 2019;54(4):549-559
pubmed: 30693832
Drug Alcohol Depend. 2019 Nov 1;204:107592
pubmed: 31586804
Subst Use Misuse. 2021;56(11):1687-1696
pubmed: 34279180
J Consult Clin Psychol. 2021 Jan;89(1):58-71
pubmed: 33507776
Am J Addict. 2014 May-Jun;23(3):205-10
pubmed: 24724876
Am J Addict. 2009 Jul-Aug;18(4):294-300
pubmed: 19444733
Addiction. 2017 Dec;112(12):2191-2201
pubmed: 28603836
J Subst Abuse Treat. 2020 Apr;111:11-15
pubmed: 32087833
N Engl J Med. 2021 Jul 22;385(4):352-356
pubmed: 34289278
JAMA Psychiatry. 2020 Dec 1;77(12):1209-1210
pubmed: 32609317
Med Care. 2021 Mar 1;59(3):238-244
pubmed: 33165146
Am J Public Health. 2020 Feb;110(2):244-250
pubmed: 31855487
NCHS Data Brief. 2020 Dec;(394):1-8
pubmed: 33395384
Drug Alcohol Depend. 2020 Jun 3;213:108089
pubmed: 32531703
Drug Alcohol Depend. 2020 Sep 1;214:108162
pubmed: 32652380
Subst Use Misuse. 2014 May;49(6):639-44
pubmed: 24093526
PLoS Med. 2018 Dec 26;15(12):e1002715
pubmed: 30586362
J Psychoactive Drugs. 2018 Jul-Aug;50(3):206-213
pubmed: 29608132
Drug Alcohol Depend. 2018 Apr 1;185:367-373
pubmed: 29524874
Drug Alcohol Depend. 2021 Jan 1;218:108416
pubmed: 33278761
MMWR Morb Mortal Wkly Rep. 2020 Mar 27;69(12):317-323
pubmed: 32214077
Subst Abuse Rehabil. 2016 Sep 29;7:143-154
pubmed: 27729825
JAMA Psychiatry. 2017 May 1;74(5):511-519
pubmed: 28297025
Int J Drug Policy. 2018 May;55:131-148
pubmed: 29625796
Drug Alcohol Rev. 2017 Mar;36(2):160-170
pubmed: 27286742
Am J Public Health. 2017 Nov;107(11):1760-1763
pubmed: 28933938
Arch Pediatr Adolesc Med. 2006 Sep;160(9):876-82
pubmed: 16953009
Subst Use Misuse. 2020;55(11):1781-1789
pubmed: 32441178
Addiction. 2020 Feb;115(2):201-217
pubmed: 31454123
Int J Drug Policy. 2020 Sep;83:102849
pubmed: 32653668
ACS Chem Neurosci. 2018 Oct 17;9(10):2373-2378
pubmed: 29602278
Curr HIV/AIDS Rep. 2010 May;7(2):99-106
pubmed: 20425564
J Urban Health. 2005 Mar;82(1 Suppl 1):i71-8
pubmed: 15738318
Drug Alcohol Depend. 2018 Jan 1;182:86-92
pubmed: 29175463
Drug Alcohol Depend. 2020 Nov 1;216:108323
pubmed: 33032064
Drug Alcohol Depend. 2018 Dec 1;193:14-20
pubmed: 30326396
NCHS Data Brief. 2021 Apr;(406):1-8
pubmed: 33814035
J Subst Abuse Treat. 2021 Feb;121:108180
pubmed: 33127196
Expert Rev Clin Pharmacol. 2017 Mar;10(3):305-314
pubmed: 27927042
Eval Program Plann. 2017 Oct;64:49-56
pubmed: 28531654
Int J Drug Policy. 2021 May;91:103098
pubmed: 33476863
Am J Addict. 2017 Mar;26(2):145-151
pubmed: 28177556
BMJ. 2015 Nov 03;351:h5790
pubmed: 26537832
J Subst Abuse Treat. 2016 Apr;63:1-9
pubmed: 26882891
Am J Drug Alcohol Abuse. 2020 May 3;46(3):273-288
pubmed: 31809217
Drug Alcohol Depend. 2020 Nov 1;216:108307
pubmed: 33007699
Drug Alcohol Depend. 2021 Apr 1;221:108580
pubmed: 33674175
J Subst Abuse Treat. 2020 Feb;109:80-85
pubmed: 31810594
Drug Alcohol Depend. 2015 Jul 1;152:272-6
pubmed: 25977204
Addiction. 2010 Sep;105(9):1507-9
pubmed: 20707772
J Addict Med. 2021 Jan-Feb 01;15(1):34-39
pubmed: 32530888
Addiction. 2020 May;115(5):946-958
pubmed: 31912625
Public Health Rep. 2002;117 Suppl 1:S135-45
pubmed: 12435837
J Subst Abuse Treat. 2017 Nov;82:41-47
pubmed: 29021114
J Neurol Sci. 2020 Nov 15;418:117149
pubmed: 33002757
Am J Public Health. 2020 Apr;110(4):509-516
pubmed: 32078347